David Mott - Insider Trading & Ownership
-
Entity
-
Individual
-
Location
-
1119 St. Paul Street, Baltimore, MD
-
Summary
-
The estimated net worth of David Mott is at least $16.3M dollars as of February 26, 2025. David Mott is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $10.1M. David Mott is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. David Mott is the Director of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. (MRSN) stock worth about $1.62M. David Mott is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $1.09M. David Mott is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K.